A patented technology that combines individual immune fingerprinting with an AI-powered data integration platform
Industry-leading expertise in decoding immune signatures
From a decade of research in human immunology using powerful single-cell omics technologies, led by Surge co-founder Brice Gaudilliere, we have identified unique immune signatures that drive individual patients’ clinical outcomes after major physical stress.
An innovative technique to mimic the immune response
By mimicking the response of the immune system to trauma-related stress, we predict patients’ outcomes in a range of clinical scenarios, including surgery, traumatic injury, stroke, infection, and pregnancy.
A state-of-the-art technology platform to transform clinical information into actionables
By honing in on a selective set of only the highly predictive features, allows researchers and clinicians to focus on the most impactful interventions.
Knowledge gained from these immune signatures allows healthcare providers to act with targeted treatment strategies and personalized interventions to improve outcomes.
Our technology also provides a unique opportunity to develop and monitor the biological and risk-modulating effect of new therapeutic interventions throughout the care pathway.
